The OTC Monograph drug user fee program, which we refer to as “OMUFA,” is similar to our other user fee programs, such as the Prescription Drug User Fee Act (PDUFA).
Similar Posts
Orange Book Preface
Preface to Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) provides info on how the book came to be, relevant terms and codes, user responsibilities and more.Raw Bistro Pet Fare Voluntarily Recalls Frozen Beef Entrée Because of Possible Salmonella Health Risk
October 9, 2025 – Raw Bistro Pet Fare, Cannon Falls, MN is voluntarily recalling two product sizes of its frozen beef dog food because they may be contaminated with Salmonella.Sunscreen Innovation Act | SIA
The Sunscreen Innovation Act (SIA) was enacted on November 26, 2014 to provide an alternative process for the review of safety and effectiveness of nonprescription sunscreen active ingredients.Aquastar (USA) Corp Recalls Shrimp Because of Possible Health Risk
October 17, 2025, AquaStar (USA) Corp of Seattle, WA is voluntarily recalling a limited quantity of frozen shrimp imported from Indonesia because they may have been prepared, packed, or held under conditions whereby they may have become exposed to very low levels of cesium-137 (Cs-137).Diagnostic Intravascular Catheter Recall: Conavi Removes Novasight Hybrid Catheters
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramAnazaoHealth Corporation. Las Vegas, NV. 483 issued 08/08/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 08/08/2025
Short Title (70 char) AnazaoHealth Corporation. Las Vegas, NV. 483 issued 08/08/2025
FEI Number 3011152407
Firm Name AnazaoHealth Corporation
Record Type 483
State NV
Establishment Type Outsourcing Fa